Osterweis Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15
Closed -$1.02K 315
2025
Q1
$1.02K Buy
+15
New +$898 ﹤0.01% 236
2023
Q2
Sell
-266,767
Closed -$19.8M 213
2023
Q1
$19.8M Sell
266,767
-90,959
-25% -$7.63M 1.35% 30
2022
Q4
$33.3M Sell
357,726
-165,531
-32% -$16M 2.42% 7
2022
Q3
$49.9M Sell
523,257
-3,565
-0.7% -$353K 3.74% 3
2022
Q2
$48.8M Sell
526,822
-6,138
-1% -$599K 3.66% 3
2022
Q1
$53.9M Buy
532,960
+101,766
+24% +$10.7M 2.97% 4
2021
Q4
$44.5M Buy
431,194
+64,997
+18% +$6.01M 2.23% 8
2021
Q3
$31.1M Buy
366,197
+294,826
+413% +$24.7M 1.7% 17
2021
Q2
$5.96M Buy
+71,371
New +$5.84M 0.31% 90

Other funds holding CVS

Osterweis Capital Management's CVS Position: Q2 2025 in Review

Osterweis Capital Management sold out of CVS Health (CVS) in Q2 2025, closing a stake of 15 shares — an estimated $1.02K sold.

Osterweis Capital Management first reported a position in CVS in Q2 2021 and held it in 9 quarters. The position peaked at $53.9M in Q1 2022. 1,758 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • Osterweis Capital Management reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
  • Osterweis Capital Management sold 15 CVS Health shares in Q2 2025, an estimated $1.02K.
  • Osterweis Capital Management first reported a position in CVS Health in Q2 2021 and held it in 9 quarters.
  • Osterweis Capital Management's CVS Health position peaked at $53.9M in Q1 2022.
  • 1,758 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Osterweis Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.